Skip to main content
Clinical Trials/NL-OMON36418
NL-OMON36418
Completed
Not Applicable

Microvascular lesions in the brain in Alzheimer*s disease: identification of a novel biomarker with 7T MRI - Cerebral microvascular lesions in AD

niversitair Medisch Centrum Utrecht0 sites50 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
niversitair Medisch Centrum Utrecht
Enrollment
50
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Observational invasive

Investigators

Sponsor
niversitair Medisch Centrum Utrecht

Eligibility Criteria

Inclusion Criteria

  • Participant of \*parelsnoer neurodegeneratieve ziekten\* project and diagnosed with (possible) Alzheimer's disease.;For parelsnoer:
  • referred to memory clinic
  • subjective and/or objective cognitive impairment
  • CDR 0, 0\.5 or 1
  • MMSE 20 or higher

Exclusion Criteria

  • Normal pressure Hydrocephalus, M. Huntington
  • Recent CVA (\<2 years), or CVA with subsequent (within 3 months) cognitive deterioration
  • (History of) Schizophrenia, other psychotic disorders
  • Major depression
  • Alcohol abuse
  • Brain tumour, epilepsia, encephalitis
  • Absence of reliable informant
  • Expectation that patient can not be followed for at least 1 year.
  • Contra\-indication for 7 Tesla MR imaging

Outcomes

Primary Outcomes

Not specified

Similar Trials